Overview
Noramco is a leading manufacturer of controlled substance active pharmaceutical ingredients (APIs), specializing in opioids, cannabinoids, and stimulants. Headquartered in Delaware, USA, the company provides DEA-compliant development and production from kilos to multi-ton scales, supporting pharmaceutical innovation with high-purity synthetic and semi-synthetic compounds. Noramco holds approvals from FDA, Health Canada, MHRA, and EMA, ensuring global regulatory compliance.
Frequently asked questions
- What APIs does Noramco specialize in?
- Noramco specializes in controlled substance APIs including opioids, cannabinoids, stimulants, and non-opioid products, produced from narcotic raw materials with high purity.
- What regulatory approvals does Noramco hold?
- Noramco is compliant with DEA regulations and holds approvals from United States FDA, Canada Health Canada, UK MHRA, and Europe EMA.
- What are Noramco's production capabilities and geographies?
- Headquartered in Delaware, USA, Noramco offers global operations with DEA-compliant security and capacity from kilos to multi-ton supply, including building blocks, intermediates, and custom synthesis.